Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/32022
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorISHIDA, Tatiane Sayuri
dc.contributor.authorSAKAI, Maria Cristina
dc.contributor.authorMELO, Daniela Oliveira de
dc.date.accessioned2019-05-30T13:57:14Z
dc.date.available2019-05-30T13:57:14Z
dc.date.issued2018
dc.identifier.citationBRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, v.54, n.4, article ID UNSP e18008, 10p, 2018
dc.identifier.issn1984-8250
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/32022
dc.description.abstractThe objective of the study was to evaluate the use of human albumin in a Brazilian university hospital, in compliance with the institutional protocol and other clinical guidelines, taking into account the therapeutic indications and the dosage regimens. Data was obtained from the pharmacy dispensing records of human albumin, the requests for use it and, when available, the patient's records between January and October 2017. After evaluation the therapeutic indications and the dosage regimens were classified as ""appropriate"" and ""inappropriate"". The analysis of 98 requests showed that, when compared to the institutional protocol, 54 (55.1%) requests had an inappropriate therapeutic indication. However, when a comparison was made between 25 medical records (54 requests) and other clinical guidelines, it was observed that the therapeutic indication had none classified as inappropriate. In addition, 16 (29.7%) requests were considered inappropriate in relation to dosage regimens. From these results, it was possible to conclude that although the use of human albumin in the hospital was associated to a clinical protocol, it was outdated. Thus, it is possible to affirm that not only the adoption of a clinical protocol, but its periodical updating is an important strategy to promote the rational use of drugs.eng
dc.description.sponsorshipMinistry of Health
dc.description.sponsorshipMinistry of Education
dc.language.isoeng
dc.publisherUNIV SAO PAULO, CONJUNTO QUIMICASeng
dc.relation.ispartofBrazilian Journal of Pharmaceutical Sciences
dc.rightsopenAccesseng
dc.subjectAlbumins/drug utilization revieweng
dc.subjectHealth serviceseng
dc.subjectUniversity Hospital/Brazileng
dc.subjectDrugs/useeng
dc.subject.otherseptic shockeng
dc.subject.otherguidelineseng
dc.subject.othermanagementeng
dc.titleThe appropriate use of human albumin in a Brazilian University Hospital: therapeutic indication and dosage regimeneng
dc.typearticleeng
dc.rights.holderCopyright UNIV SAO PAULO, CONJUNTO QUIMICASeng
dc.identifier.doi10.1590/s2175-97902018000418008
dc.subject.wosPharmacology & Pharmacyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalISHIDA, Tatiane Sayuri:Univ Sao Paulo, Univ Hosp, Pharm Dept, Sao Paulo, SP, Brazil
hcfmusp.author.externalMELO, Daniela Oliveira de:Univ Fed Sao Paulo, Pharmaceut Sci Dept, Diadema, SP, Brazil
hcfmusp.description.articlenumberUNSP e18008
hcfmusp.description.issue4
hcfmusp.description.volume54
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000464225600001
hcfmusp.origem.idSCIELO:S1984-82502018000400631
hcfmusp.origem.id2-s2.0-85065928323
hcfmusp.publisher.citySAO PAULOeng
hcfmusp.publisher.countryBRAZILeng
hcfmusp.relation.referenceBernardi M, 2014, J CLIN EXP HEPATOL, V4, P302, DOI 10.1016/j.jceh.2014.08.007eng
hcfmusp.relation.referenceBorges WM, 2010, EINSTEIN-SAO PAULO, V8, P215, DOI 10.1590/S1679-45082010AO1630eng
hcfmusp.relation.referenceCaraceni P, 2016, DIGEST LIVER DIS, V48, P4, DOI 10.1016/j.dld.2015.11.008eng
hcfmusp.relation.referenceCaraceni P, 2013, BLOOD TRANSFUS-ITALY, V11, pS18, DOI 10.2450/2013.005seng
hcfmusp.relation.referenceCaraceni P, 2013, EUR J INTERN MED, V24, P721, DOI 10.1016/j.ejim.2013.05.015eng
hcfmusp.relation.referenceCasuccio A, 2015, INT J QUAL HEALTH C, V27, P154, DOI 10.1093/intqhc/mzv005eng
hcfmusp.relation.referenceCorrea TD, 2015, EINSTEIN-SAO PAULO, V13, P462, DOI 10.1590/S1679-45082015RW3273eng
hcfmusp.relation.referenceGuy's and St. Thomas' NHS Foundation Trust, 2015, GUID US HUM ALB SOLeng
hcfmusp.relation.referenceLiumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P216, DOI 10.2450/2009.0094-09eng
hcfmusp.relation.referenceLyu PF, 2016, CRIT CARE MED, V44, P1307, DOI 10.1097/CCM.0000000000001638eng
hcfmusp.relation.referenceMatos Guacira Corrêa de, 2005, Cad. Saúde Pública, V21, P1224, DOI 10.1590/S0102-311X2005000400025eng
hcfmusp.relation.referenceMedeiros DNM, 2015, PEDIATR EMERG CARE, V31, pe11, DOI 10.1097/PEC.0000000000000601eng
hcfmusp.relation.referenceNational Plasma Products Expert Advisory Group-Scotland NHS, 2016, CLIN GUID HUM ALB USeng
hcfmusp.relation.referenceOntario Regional Blood Coordinating Network, 2012, ONT ALB ADM RECeng
hcfmusp.relation.referenceStanford Health Care, 2017, GUID INTR ALB ADM STeng
hcfmusp.relation.referenceTULLIS JL, 1977, JAMA-J AM MED ASSOC, V237, P355eng
hcfmusp.relation.referenceTULLIS JL, 1977, JAMA-J AM MED ASSOC, V237, P460, DOI 10.1001/jama.237.5.460eng
hcfmusp.relation.referenceVaglio S, 2014, EUR J INTERN MED, V25, pE31, DOI 10.1016/j.ejim.2013.09.010eng
hcfmusp.relation.referenceValerio C, 2016, WORLD J HEPATOL, V8, P345, DOI 10.4254/wjh.v8.i7.345eng
hcfmusp.relation.referenceVargas E, 1997, EUR J CLIN PHARMACOL, V52, P465, DOI 10.1007/s002280050320eng
hcfmusp.relation.referenceVERMEULEN LC, 1995, ARCH INTERN MED, V155, P373, DOI 10.1001/archinte.155.4.373eng
dc.description.indexWoSeng
dc.identifier.eissn2175-9790
hcfmusp.citation.scopus1-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HU
Hospital Universitário - HU


Files in This Item:
File Description SizeFormat 
art_ISHIDA_The_appropriate_use_of_human_albumin_in_a_2018.PDFpublishedVersion (English)309.7 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.